Earnings Analyzer
Stock earnings page

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Track the next or latest earnings date for BridgeBio Oncology Therapeutics, Inc., review consensus estimates, and see cached AI analysis for recent quarterly results.

Recent earnings news

Buy BBOT Stock – BBOT Stock Quote Today & Investment Insights - Public.com
public.com · Recent

Looking to buy BBOT Stock? Get the latest BBOT quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.

Why Babcock & Wilcox Stock Surged After Missing Earnings Today | The Motley Fool
fool.com · 2 weeks ago

Babcock & Wilcox missed badly on earnings this morning. But Babcock's order book just got 20x bigger, which should power profits this year and next. Babcock & Wilcox (BW +9.66%) stock, the Akron, Ohio-based manufacturer of steam boilers and hydrogen gas production equipment, exploded (in a ...

Earnings Update: Boot Barn Holdings, Inc. (NYSE:BOOT) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
finance.yahoo.com · 1 week ago

There's been a notable change in appetite for Boot Barn Holdings, Inc. ( NYSE:BOOT ) shares in the week since its...

BBOT Dips Close to Lows With One Cancer Drug Update Steering Trade
www.bez-kabli.pl · 1 day ago

BridgeBio Oncology Therapeutics ... cancer drug results set for this year. BBOT last traded near $8.90, in a session range of $8.85 to $9.25. The Nasdaq Composite was up roughly 0.4%. Timing is in play here. U.S. stocks traded normal Friday hours before the Memorial Day ...

BridgeBio Oncology grants 32,675 inducement options | BBOT Stock News
www.stocktitan.net · 2 weeks ago

BBOT gained 3% while peers were mixed: AVXL +1.57%, IMNM +2.18%, IVA +3.2%, GERN flat, PRAX -0.52%. No coordinated sector move evident. Common Catalyst Select peers had their own catalysts (e.g., IMNM earnings, GERN clinical meeting news), pointing to stock-specific rather than sector-wide drivers.

Latest earnings date

Feb 11, 2026

Time not specified

Fiscal quarter: Dec/2025

EPS estimate: -$0.61

Revenue estimate: N/A

Market cap: $867.08M

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week
Date Quarter Report window EPS est. Revenue est.
Feb 11, 2026 Dec/2025 Time not specified -$0.61 N/A